Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,251 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects.
Krystal JH, Abi-Saab W, Perry E, D'Souza DC, Liu N, Gueorguieva R, McDougall L, Hunsberger T, Belger A, Levine L, Breier A. Krystal JH, et al. Among authors: levine l. Psychopharmacology (Berl). 2005 Apr;179(1):303-9. doi: 10.1007/s00213-004-1982-8. Epub 2004 Aug 10. Psychopharmacology (Berl). 2005. PMID: 15309376 Clinical Trial.
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.
Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, Renard D, Brady KT, Trzepacz PT, Schuh LM, Ahrbecker LM, Levine LR; Atomoxetine ADHD/SUD Study Group. Wilens TE, et al. Among authors: levine lr. Drug Alcohol Depend. 2008 Jul 1;96(1-2):145-54. doi: 10.1016/j.drugalcdep.2008.02.009. Epub 2008 Apr 9. Drug Alcohol Depend. 2008. PMID: 18403134 Clinical Trial.
Functional outcomes in the treatment of adults with ADHD.
Adler LA, Spencer TJ, Levine LR, Ramsey JL, Tamura R, Kelsey D, Ball SG, Allen AJ, Biederman J. Adler LA, et al. Among authors: levine lr. J Atten Disord. 2008 May;11(6):720-7. doi: 10.1177/1087054707308490. Epub 2007 Oct 29. J Atten Disord. 2008. PMID: 17968028 Clinical Trial.
1,251 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page